Pharmadrug Inc.
LMLLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,024 | $1,471 | $1,509 | $1,031 |
| - Cash | $6 | $18 | $75 | $75 |
| + Debt | $1,490 | $1,434 | $1,380 | $1,349 |
| Enterprise Value | $2,508 | $2,887 | $2,814 | $2,305 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$18 | -$18 | -$52 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$77 | -$73 | -$100 | $6 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | -0.001 | -0.001 | 0.001 |
| % Growth | -42.9% | 22.2% | -228.6% | – |
| Operating Cash Flow | – | -$0 | -$0 | $1 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$0 | -$0 | $1 |